A Phase I Clinical Trial of Combined Cryotherapy and Intra-tumoral Immunotherapy With Autologous Immature Dendritic Cells in Men With Castration Resistant Prostatic Cancer and Metastases to Lymph Nodes and/or Bone Pre or Post Chemotherapy
Phase of Trial: Phase I
Latest Information Update: 22 Jul 2016
At a glance
- Drugs ACT 2001 (Primary) ; Cyclophosphamide; Ipilimumab
- Indications Prostate cancer
- Focus Adverse reactions
- Acronyms CryoIT
- Sponsors Alden Cancer Therapy II
- 19 Jul 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 19 Jul 2016 Planned primary completion date changed from 1 Jun 2016 to 1 May 2017.
- 20 May 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.